CN103823062A - Shigella boydii enzyme-linked immunosorbent assay kit - Google Patents
Shigella boydii enzyme-linked immunosorbent assay kit Download PDFInfo
- Publication number
- CN103823062A CN103823062A CN201410065159.1A CN201410065159A CN103823062A CN 103823062 A CN103823062 A CN 103823062A CN 201410065159 A CN201410065159 A CN 201410065159A CN 103823062 A CN103823062 A CN 103823062A
- Authority
- CN
- China
- Prior art keywords
- antibody
- mab05
- kit
- salmonella choleraesuls
- monoclonal antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000607766 Shigella boydii Species 0.000 title abstract description 5
- 238000008157 ELISA kit Methods 0.000 title abstract description 3
- 238000001514 detection method Methods 0.000 claims abstract description 28
- 241000607142 Salmonella Species 0.000 claims description 46
- 239000007788 liquid Substances 0.000 claims description 26
- 102000004190 Enzymes Human genes 0.000 claims description 22
- 108090000790 Enzymes Proteins 0.000 claims description 22
- 210000004408 hybridoma Anatomy 0.000 claims description 20
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 19
- 230000001900 immune effect Effects 0.000 claims description 14
- 241000894006 Bacteria Species 0.000 claims description 10
- 239000013641 positive control Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000013642 negative control Substances 0.000 claims description 9
- 239000007790 solid phase Substances 0.000 claims description 9
- 239000001888 Peptone Substances 0.000 claims description 8
- 108010080698 Peptones Proteins 0.000 claims description 8
- 238000006911 enzymatic reaction Methods 0.000 claims description 8
- 235000019319 peptone Nutrition 0.000 claims description 8
- 230000009849 deactivation Effects 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000012360 testing method Methods 0.000 abstract description 22
- 244000052616 bacterial pathogen Species 0.000 abstract description 5
- 238000000034 method Methods 0.000 description 33
- 229940088598 enzyme Drugs 0.000 description 22
- 210000004027 cell Anatomy 0.000 description 18
- 239000000523 sample Substances 0.000 description 15
- 239000000243 solution Substances 0.000 description 13
- 239000000758 substrate Substances 0.000 description 10
- 230000037029 cross reaction Effects 0.000 description 8
- 239000012634 fragment Substances 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 230000004927 fusion Effects 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 239000000427 antigen Substances 0.000 description 6
- 108091007433 antigens Proteins 0.000 description 6
- 102000036639 antigens Human genes 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000007789 sealing Methods 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 5
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 229940005654 nitrite ion Drugs 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 108091007491 NSP3 Papain-like protease domains Proteins 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000003053 immunization Effects 0.000 description 4
- 238000002649 immunization Methods 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 3
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 3
- 241000193755 Bacillus cereus Species 0.000 description 3
- 241001135265 Cronobacter sakazakii Species 0.000 description 3
- 208000004232 Enteritis Diseases 0.000 description 3
- 241001646719 Escherichia coli O157:H7 Species 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 201000005010 Streptococcus pneumonia Diseases 0.000 description 3
- 241000193998 Streptococcus pneumoniae Species 0.000 description 3
- 241001148129 Yersinia ruckeri Species 0.000 description 3
- 239000008351 acetate buffer Substances 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 208000028104 epidemic louse-borne typhus Diseases 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 244000078673 foodborn pathogen Species 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 206010061393 typhus Diseases 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 241001416149 Ovis ammon Species 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000010241 blood sampling Methods 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000013016 damping Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 239000003547 immunosorbent Substances 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- -1 urase Substances 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- WBODDOZXDKQEFS-UHFFFAOYSA-N 1,2,3,4-tetramethyl-5-phenylbenzene Chemical group CC1=C(C)C(C)=CC(C=2C=CC=CC=2)=C1C WBODDOZXDKQEFS-UHFFFAOYSA-N 0.000 description 1
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 108010047041 Complementarity Determining Regions Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 101150082208 DIABLO gene Proteins 0.000 description 1
- 102100033189 Diablo IAP-binding mitochondrial protein Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 241000872931 Myoporum sandwicense Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241000353135 Psenopsis anomala Species 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 239000005030 aluminium foil Substances 0.000 description 1
- 238000011091 antibody purification Methods 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 1
- GEWYFWXMYWWLHW-UHFFFAOYSA-N azanium;octanoate Chemical compound [NH4+].CCCCCCCC([O-])=O GEWYFWXMYWWLHW-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000002458 cell surface marker Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000004153 renaturation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000003151 transfection method Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/24—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- G01N2333/255—Salmonella (G)
Abstract
The invention discloses an enzyme-linked immunosorbent assay kit for detecting shigella boydii. The kit contains two strains of monoclonal antibodies which can be specifically combined in shigella boydii, one strain is a monoclonal antibody Mab05-F10 specialized as a capture antibody, and the other strain is a monoclonal antibody Mab05-D10 as a detection antibody. A large number of tests confirm that the kit can be specifically and efficiently detect shigella boydii, moreover, has no cross reaction with other 77 kinds of common pathogenic bacteria, and is a pathogenic bacteria detection product with excellent performance.
Description
Technical field
The invention belongs to biotechnology and field of immunology, be specifically related to a kind of enzyme linked immunological kit that detects Salmonella choleraesuls.
Background technology
Salmonella choleraesuls (Shigella boydii) belong to Shigella C group, it is a kind of important food-borne pathogens, can pass through the animal products such as contaminated meat, egg, fish and goods thereof, shelled melon seeds etc. enter human body, cause heating, stomachache, tenesmus, sometimes showing as whole body toxicity symptom is toxic dysentery, and treatment does not thoroughly transfer to chronic.
The detection of Salmonella choleraesuls at present mainly depends on the biochemical identification of GB defined, and its shortcoming is that complex operation, sense cycle are longer, cannot adapt to a large amount of sample examinations.Immunology detection is quick, accurate, the most stable fast detecting means that occur in recent years; but there is no at present the fast detecting product that can apply to detect practice both at home and abroad; this patent is take Salmonella choleraesuls as detecting target, and technology required for protection relates to Salmonella choleraesuls fast detecting product.
Summary of the invention
The object of this invention is to provide a kind of kit that detects Salmonella choleraesuls.
And then, the invention provides a kind of enzyme linked immunological kit for detection of Salmonella choleraesuls, described kit contains:
(a) solid phase carrier, on described solid phase carrier, be coated with as the anti-Salmonella choleraesuls monoclonal antibody Mab05-F10 that catches antibody, described anti-Salmonella choleraesuls monoclonal antibody Mab05-F10 is Mab05-F10 by mouse hybridoma cell, and CGMCC No.7712 produces;
(b) container a, in described container a, be equipped with as the anti-Salmonella choleraesuls monoclonal antibody Mab05-D10 that detects antibody, described anti-Salmonella choleraesuls monoclonal antibody Mab05-D10 is Mab05-D10 by mouse hybridoma cell, and CGMCC No.7710 produces.
In a preference, described solid phase carrier is enzyme reaction plate.
In another preference, described detection antibody is with detectable label.
In another preference, described detectable label is horseradish peroxidase.
In another preference, described kit also contains positive control and negative control.
In another preference, the Salmonella choleraesuls bacterium liquid that described positive control is deactivation, the buffered peptone water that described negative control is sterilizing.
The details of various aspects of the present invention will be able to detailed description in chapters and sections subsequently.By below and the description of claim, feature of the present invention, object and advantage will be more obvious.
Accompanying drawing explanation
The SDS-PAGE electrophoretogram of Fig. 1 monoclonal antibody of the present invention
Lane1：Mab05-D10，Lane2：Mab05-F10
Embodiment
The inventor's research shows, using Salmonella choleraesuls as immunogene, immunity Balb/c mouse, separation and purification obtains the anti-Salmonella choleraesuls monoclonal antibody of two strains, be Mab05-F10, preserving number CGMCC No.7712 and Mab05-D10, preserving number CGMCC No.7710, the antibody titer of above-mentioned two strain monoclonal antibodies can reach 1:100000, and it can specificity, be combined with Salmonella choleraesuls efficiently.Using the coated enzyme reaction plate of said monoclonal antibody Mab05-F10 as catching antibody, as detecting antibody, make enzyme-linked immunologic detecting kit with the said monoclonal antibody Mab05-D10 of horseradish peroxidase-labeled.Result demonstration, above-mentioned Salmonella choleraesuls detection kit detection sensitivity reaches 10
5cfu/ml, has advantages of that repeatability, accuracy are good, and between hole, error is less than 5%, and in plate, CV is less than 3%.It amounts to 77 kinds of equal no cross reactions of pathogenetic bacteria with single Liszt of increasing, mouse typhus sramana, enteritis sramana, Fu Shi will he, Song Nei Shi will he, Boydii will he, enterohemorrhagic Escherichia coli O 157: H7, Enterobacter sakazakii, small intestine Yersinia ruckeri, streptococcus pneumonia, bacillus cereus etc.
On this basis, the inventor and then according to DASELISA immunization, through test repeatedly, finally obtained a kind of can be fast, efficient detection eats the enzyme linked immunological kit of source property Salmonella choleraesuls.
Antibody
The present invention includes the anti-Salmonella choleraesuls monoclonal antibody of two strains.It is Mab05-F10(CGMCC No.7712 that the anti-Salmonella choleraesuls monoclonal antibody of two strain of the present invention can be utilized mouse hybridoma cell) and mouse hybridoma cell be Mab05-D10(CGMCC No.7710) respectively secretion produce.
The present invention includes the monoclonal antibody of the corresponding amino acid sequence with anti-Salmonella choleraesuls monoclonal antibody Mab05-F10 and Mab05-D10, and there is other protein or protein conjugate and the fusion expressed product of these chains.Particularly, the present invention includes and have containing hypervariable region (complementary determining region, any protein of light chain CDR) and heavy chain or protein conjugate and fusion expressed product (being immune conjugate and fusion expressed product), as long as the hypervariable region of this hypervariable region and light chain of the present invention and heavy chain is identical or at least 90% homology, preferably at least 95% homology.As is known to the person skilled in the art, immune conjugate and fusion expressed product comprise: medicine, toxin, cell factor (cytokine), radioactive nuclide, enzyme and other diagnosis or treatment molecule be combined with anti-Salmonella choleraesuls monoclonal antibody or its fragment and formation conjugate.The present invention also comprises cell surface marker thing or the antigen of being combined with anti-Salmonella choleraesuls monoclonal antibody or its fragment.
For anti-Salmonella choleraesuls monoclonal antibody heavy chain of the present invention and sequence of light chain, can measure by conventional method.(complementarity determining region, CDR) is interesting especially for the hypervariable region of anti-Salmonella choleraesuls monoclonal antibody V chain or complementary determining region, because relate at least partly conjugated antigen in them.Therefore, the present invention includes those and there is light chain immunoglobulin with CDR and the molecule of weight chain variable chain, as long as its CDR and anti-Salmonella choleraesuls monoclonal antibody CDR have the homology of more than 90% (preferably more than 95%).The present invention not only comprises complete monoclonal antibody, also comprises and has immunocompetent antibody fragment, as Fab or (Fab ')
2fragment; Heavy chain of antibody; Light chain of antibody.
The present invention also provides the DNA molecular of above-mentioned immunoglobulin (Ig) or its fragment.The sequence of these DNA moleculars can be used routine techniques, and utilizing mouse hybridoma cell is Mab05-F10(CGMCC No.7712) and Mab05-D10(CGMCC No.7710) obtain.In addition, also the coded sequence of light chain and heavy chain can be merged, form single-chain antibody.
Once obtain relevant sequence, just can obtain in large quantity relevant sequence with recombination method.This is normally cloned into carrier, then proceeds to cell, is then separated and obtains relevant sequence from the host cell propagation by conventional method.
In addition, also can synthesize relevant sequence by artificial synthetic method, especially fragment length more in short-term.Conventionally, by first synthetic multiple small fragments, and then connect and can obtain the fragment that sequence is very long.
At present, can be completely obtain the DNA sequence dna of code book invention albumen (or its fragment, or derivatives thereof) by chemosynthesis.Then this DNA sequence dna can be introduced in the various existing DNA molecular (or as carrier) and cell that in this area, oneself knows.In addition, also can will suddenly change and introduce in protein sequence of the present invention by chemosynthesis.
The invention still further relates to the carrier that comprises above-mentioned suitable DNA sequence dna and suitable promoter or control sequence.These carriers can be for transforming suitable host cell, with can marking protein.
Host cell can be prokaryotic, as bacterial cell; Or the eukaryotic such as low, as yeast cells; Or higher eucaryotic cells, as mammalian cell.
Can carry out with routine techniques well known to those skilled in the art with recombinant DNA transformed host cell.When host is prokaryotes during as Enterohemorrhagic E.coli, the competent cell that can absorb DNA can, in exponential growth after date results, be used CaC1
2method processing, step used is well-known in this area.Another kind method is to use MgC1
2.If needed, transform and also can be undertaken by the method for electroporation.When host is eucaryote, can use following DNA transfection method: calcium phosphate precipitation, conventional mechanical method is as microinjection, electroporation, liposome packing etc.
The transformant obtaining can be cultivated by conventional method, expresses the polypeptide of coded by said gene of the present invention.According to host cell used, nutrient culture media used in cultivation can be selected from various conventional mediums.Under the condition that is suitable for host cell growth, cultivate.When host cell grows into after suitable cell density, the promoter of selecting with suitable method (as temperature transition or chemical induction) induction, cultivates cell a period of time again.
Extracellular can be expressed or be secreted into recombinant polypeptide in the above methods in cell or on cell membrane.If needed, can utilize its physics, the separating by various separation methods with other characteristic and the albumen of purification of Recombinant of chemistry.These methods are well-known to those skilled in the art.The example of these methods includes, but are not limited to: conventional renaturation processing, with the combination of protein precipitant processing (salt analysis method), centrifugal, the broken bacterium of infiltration, ultrasonic processing, ultracentrifugation, sieve chromatography (gel filtration), adsorption chromatography, ion-exchange chromatography, high performance liquid chroma-tography (HPLC) and other various liquid chromatography (LC) technology and these methods.
Anti-Salmonella choleraesuls monoclonal antibody Mab05-D10 of the present invention and Mab05-F10, its height of tiring (can reach 1:100000), can detect specifically, efficiently Salmonella choleraesuls, amount to 77 kinds of equal no cross reactions of pathogenetic bacteria with single Liszt of increasing, mouse typhus sramana, enteritis sramana, Fu Shi will he, Song Nei Shi will he, Boydii will he, enterohemorrhagic Escherichia coli O 157: H7, Enterobacter sakazakii, small intestine Yersinia ruckeri, streptococcus pneumonia, bacillus cereus etc., this is maximum innovative point of the present invention.Said monoclonal antibody Mab05-D10 can use horseradish peroxidase, alkaline phosphatase, nanogold particle mark, uses in specific manner as detecting antibody.Said monoclonal antibody Mab05-F10, in various detections are used, can use as catching antibody in specific manner.
Detection kit
The inventor is through studying widely and testing, be surprised to find that, being Mab05-F10(CGMCC No.7712 when adopting mouse hybridoma cell) the anti-Salmonella choleraesuls monoclonal antibody that produces is as catching after antibody capture Salmonella choleraesuls, being Mab05-D10(CGMCC No.7710 with detectable label mark by mouse hybridoma cell again) the anti-Salmonella choleraesuls monoclonal antibody that produces is as detecting antibody, can extremely effectively be incorporated into Salmonella choleraesuls, thereby detect in high sensitivity Salmonella choleraesuls by double antibodies sandwich method.
As used herein, described " sample " refers to the materials such as food, human and animal excreta, vomitus, includes but not limited to: the enrichment liquid of serum, blood plasma, ight soil, food etc.Preferably, described sample is food.
As used herein, described " seizure antibody ", " coated antibody ", " first antibody " are used interchangeably with " primary antibodie ", all refer to the described monoclonal antibody that can be incorporated into specifically Salmonella choleraesuls, it is Mab05-F10(CGMCC No.7712 by mouse hybridoma cell) produce.
Described seizure antibody can be coated on solid phase carrier.The present invention has no particular limits adopted solid phase carrier, if its can with catch antibody phase coupling (connection).For example, described solid phase carrier is enzyme reaction plate.
As used herein, described " detection antibody ", " second antibody ", " enzyme labelled antibody " are used interchangeably with " two is anti-", all refer to can specific binding in another strain monoclonal antibody of Salmonella choleraesuls, it is Mab05-D10(CGMCC No.7710 by mouse hybridoma cell) produce.
As used herein, described " specificity " refers to that antibody can only be incorporated into Salmonella choleraesuls; More particularly, refer to that those can be combined with Salmonella choleraesuls but nonrecognition and be incorporated into the antibody of other irrelevant antigen molecule.
The inventor and then according to double antibodies sandwich ratio juris, has prepared a kind of enzyme linked immunological kit that can be used for detecting Salmonella choleraesuls in sample.The way of double antibodies sandwich method routine is that seizure antibody is fixed on to carrier, then catch antibody and antigen-reactive, after washing, (described detection antibody carries detectable with detecting antibody response again, or can be combined with the material that carries detectable), finally carry out chemiluminescence or enzyme connection chromogenic reaction detection signal.And with respect to the competition law of monoclonal antibody body, the mensuration effect of double antibody sandwich method is more good, thereby only need little sample size while measuring.So adopt double antibody sandwich method no matter to have more advantage in sensitivity, degree of accuracy, accuracy, specificity and stability.
Particularly, enzyme linked immunological kit of the present invention contains:
(a) enzyme reaction plate, on described enzyme reaction plate, be coated with as the anti-Salmonella choleraesuls monoclonal antibody Mab05-F10 that catches antibody, described anti-Salmonella choleraesuls monoclonal antibody Mab05-F10 is Mab05-F10 by mouse hybridoma cell, and CGMCC No.7712 produces;
(b) container a, in described container a, be equipped with as the anti-Salmonella choleraesuls monoclonal antibody Mab05-D10 that detects antibody, described anti-Salmonella choleraesuls monoclonal antibody Mab05-D10 is Mab05-D10 by mouse hybridoma cell, and CGMCC No.7710 produces.
As optimal way of the present invention, described detection antibody is with detectable label.
As used herein, whether described " detectable label " refer to existence for determining detected sample Salmonella choleraesuls and the mark of the amount existing.Determining the seizure antibody that kit of the present invention adopts and/or detecting after antibody, can adopt the various labels of this area routine for being combined to detect with detection antibody.The present invention has no particular limits adopted label, as long as being combined with described detection antibody, and can indicate detected sample exactly after suitably processing in Salmonella choleraesuls existence whether and the label of amount be all available.Described label can directly be arranged at and detect on antibody; Or described label also can be arranged on the antiantibody of the anti-detection antibody of specificity, those skilled in the art can, according to the kind of adopted antibody and characteristic, select suitable label.For example, described label can be selected from: horseradish peroxidase (HRP), alkaline phosphatase vinegar enzyme (AP), glucose oxidase, beta-D-galactosidase, urase, hydrogen peroxidase or glucoamylase.
In the time adopting some enzyme labeling things as implied above, also need to adopt some and the substrate that enzyme is combined accordingly, thereby can report label by modes such as colour developings there is situation or amount.As used herein, described " substrate corresponding with label " refers to and can be labeled the catalysis colour developing of thing institute, detect for showing the identification signal that antibody is combined with Salmonella choleraesuls.Described substrate is for example: for adjacent benzene two limbs (OPD), tetramethyl biphenyl limb (TMB), the ABTS of horseradish peroxidase; Be used for p-nitrophenyl phosphoric acid vinegar (p-nitro phenyl phosphate, p-NPP) of alkaline phosphatase etc.Those skilled in the art can, according to the kind of adopted label and characteristic, select suitable substrate.
As optimal way of the present invention, described detection antibody is directly connected with label.More preferably, described label is HRP.With detect antibody with biotin labeling, react after again with the comparison of streptavidin HRP reacting phase, directly after finishing, directly add substrate and develop the color more simple and convenient detecting mark HRP on antibody, reaction.
In order to obtain quantitative result, the standard items of knowing multiple Salmonella choleraesuls of concentration containing oneself can also be set in testing process.Method to set up for standard items can adopt conventional method.
In order to eliminate false positive and false negative, Quality Control (contrast) also can be set in testing process.As optimal way of the present invention, the Salmonella choleraesuls bacterium liquid that described positive control is deactivation, the buffered peptone water that described negative control is sterilizing.
In addition, in order to make kit of the present invention more convenient in the time detecting, in described kit, preferably also comprise some other auxiliary reagent, described auxiliary reagent is conventional some reagent that use in ELISA kit, and the characteristic of these reagent and their compound method are all well-known to those skilled in the art.Described reagent is (but being not limited to) for example: developer, cleansing solution, stop buffer, enrichment liquid, dilution.
In addition, in described kit, also can comprise operation instructions, for the using method of the reagent wherein loading is described.
Detection principle and the beneficial effect of enzyme linked immunological kit of the present invention are as follows:
What kit of the present invention adopted is DASELISA immunization.There is an anti-Salmonella choleraesuls monoclonal antibody (seizure antibody) when pre-coated on enzyme reaction plate, add after sample solution or standard items, add again with detectable label Salmonella choleraesuls monoclonal antibody that is as anti-in another strain of horseradish peroxidase (detection antibody), the Salmonella choleraesuls that exist in sample or standard items will combine with seizure antibody coated on enzyme reaction plate, after detection antibody to be added, can form " antibody-antigen-enzyme labelled antibody " compound, through TMB(tetramethyl benzidine) colour developing after can form yellow substance, thereby in can judgement sample, whether and the amount existing the existence of Salmonella choleraesuls.
Under 450nm, measure absorbance by microplate reader.Negative control≤0.1, positive control >=0.3, experimental result is effective, otherwise that result is judged to be is invalid; Detect OD value >=0.2 o'clock, hole, be judged to be the positive; Detect hole OD value between 0.1-0.2 time, be judged to be the weak positive; Detect OD value≤0.1, hole and be judged to be feminine gender.
Test shows, Salmonella choleraesuls enzyme linked immunological kit of the present invention, has higher sensitivity and accuracy.Between plate, error is less than 5%, and in plate, CV is less than 3%.Amount to 77 kinds of equal no cross reactions of pathogenetic bacteria with single Liszt of increasing, mouse typhus sramana, enteritis sramana, Fu Shi will he, Song Nei Shi will he, Boydii will he, enterohemorrhagic Escherichia coli O 157: H7, Enterobacter sakazakii, small intestine Yersinia ruckeri, streptococcus pneumonia, bacillus cereus etc., this is maximum innovative point of the present invention.
In a word, kit of the present invention requires low, easy and simple to handle to the pre-treatment of sample, and detection limit is 105cfu/ml, specificity and good stability, and all there is no cross reaction with most of food-borne pathogens.
Below in conjunction with specific embodiment, further set forth the present invention.Should be understood that these embodiment are only not used in and limit the scope of the invention for the present invention is described.The experimental technique of unreceipted actual conditions in the following example, conventionally according to normal condition as people such as Sambrook, molecular cloning: lab guide (New York:Cold Spring Harbor Laboratory Press, 1989) condition described in, or the condition of advising according to manufacturer.Unless otherwise indicated, otherwise number percent and umber calculate by weight.
Unless otherwise defined, the familiar meaning of all specialties that use in literary composition and scientific words and one skilled in the art is identical.In addition, any method similar or impartial to described content and material all can be applicable in the present invention.The use that better implementation method described in literary composition and material only present a demonstration.
The preparation of embodiment 1. anti-Salmonella choleraesuls monoclonal antibody Mab05-F10 and Mab05-D10
One, the preparation of immunogene and positive criteria product
Salmonella choleraesuls (CICC21493) are seeded on sorbierite Mai Kangkai (SMAC) flat board, cultivate 24h for 37 ℃, picking list bacterium colony is in buffered peptone water (BPW), 37 ℃, 150r/min shaken cultivation 17h, counting, adds 0.3% formalin room temperature deactivation 1 day.Adjust Salmonella choleraesuls (CICC21493) concentration to 5 × 10 with physiological saline
9cfu/ml is as immunogene; Adjusting concentration with physiological saline is 10
8cfu/ml is as positive control standard items, the negative reference standards of buffered peptone water (BPW).
Two, the preparation of monoclonal antibody
1) animal used as test: select 38 week ages, body weight 20g left and right, female Balb/c mouse are animal used as test.
2) immunization method: every mouse peritoneal injection 0.2ml immunogene, at interval of 2 weeks with same dosage booster shots once.
3) blood sampling: from tail vein blood sampling, adopt indirect non-competing euzymelinked immunosorbent assay (ELISA) to measure antiserum titre after 3 booster immunizations.Wait to tire and no longer rise, lumbar injection is measured immunogene equally, after 3 days, carries out Fusion of Cells according to conventional method.
4) Fusion of Cells: get immune mouse spleen cell and SP2/0 myeloma cell conventional fusion under 50%PEG effect, be inoculated in respectively 96 well culture plates, be placed in 37 ℃, 5%CO
2incubator is cultivated.
5) filtering hybridoma: adopt indirect non-competing euzymelinked immunosorbent assay (ELISA), the hybridoma in screening strong positive hole, transfers them to 24 well culture plates.
6) clone cultivates and antibody preparation: carry out cloning cultivation with limiting dilution assay.When Growth of Cells is at the bottom of being paved with hole 1/10 time, then detect with same method, strong positive hole is cloned again, 3-4 time so repeatedly, until positive rate reaches 100%.Hybridoma is expanded and cultivated, be injected in through the pretreated Balb/c mouse peritoneal of paraffin oil, every 2 × 10
6individual hybridoma, 7～10 days mouse web portion protuberances, living body puncture extracts ascites.With caprylic acid-ammonium antibody purification from mouse ascites.
Three, the titration of monoclonal antibody
Salmonella choleraesuls nutrient culture media is as follows: GB: GB4789.4-2010
Buffered peptone water (BPW)
Composition: peptone 10.0g, sodium chloride 5.0g, sodium hydrogen phosphate (containing 12 water of crystallization) 9.0g, potassium dihydrogen phosphate 1.5g, distilled water 1000mL;
Method for making: each composition is added in distilled water, mix evenly, leave standstill about 10min, boil dissolving, regulate pH7.2 ± 0.2,121 ℃ of autoclavings, 15min.
The step that antibody titer is measured is as follows:
(1) saturated culture of bacteria antigen is added in corresponding hole to 100 μ l together with nutrient culture media, 4 ℃ spend the night (about wrapper sheet 36h).
(2) turned letter liquid pat dry residual liquid, with 250 μ l cleansing solutions cleaning 3 times.
(3) in each hole, add 100 μ l1%BSA, 37 ℃ of sealing 1h.
(4) turned letter liquid pat dry residual liquid, with 250 μ l cleansing solutions cleaning 3 times.
(5) in each hole, add 100 μ l serum, hatch 1h for 37 ℃.
(6) turned letter liquid pat dry residual liquid, adds 250 μ lPBST cleansing solutions washing 3 times in each hole.
(7) two of the HRP mark of 50 μ l anti-(sigma) in each hole, incubated at room 1h.
(8) soak 5min with cleansing solution, turned letter liquid also pats dry residual liquid, adds 250 μ lPBST cleansing solution washing 3 times in each hole.
(9) in each hole, add 100 μ l substrates, colour developing 30min, adds stop buffer 100 μ l also immediately at OD
450reading.
Table 1. liang strain antibody titer measurement result (OD
450)
Four, the purity analysis of monoclonal antibody
With the purity of SDS-PAGE analysis list clonal antibody, 5% spacer gel, 10% separation gel, 120V voltage, electrophoresis is to glue bottom, and gel dyes by Coomassie brilliant blue method, gel imaging analysis system observations (Fig. 1) after decolouring.
The CHARACTERISTICS IDENTIFICATION of embodiment 2. monoclonal antibody Mab05-F10 and Mab05-D10
One, monoclonal antibody subgroup identification
1, antigen coated: with the coated mountain sheep anti mouse two anti-IgG+A+M of 0.01M PBS, every hole 50 μ l, 4 ℃ of coated spending the night, discard liquid in hole next day, wash plate 3 times.
2, sealing: every hole adds 1%BSA200 μ l, and 4 ℃ of sealings are spent the night.Pat dry plank next day and do not wash plate.
3, add monoclonal antibody hybridoma cell supernatant, 8 micropores of each sample, every hole 50 μ l.37 ℃, hatch 1h.
4, wash after plate 4 times, add respectively the rabbit anti-mouse igg 1 of specific bond, IgG2a, IgG2b, IgG3, IgA, IgM, κ, λ, hatches 1h for 37 ℃.
5, wash after plate 4 times, every hole adds the anti-IgG(H+L of the anti-rabbit two of the horseradish peroxidase-labeled of having diluted), 37 ℃, hatch 30min.
6, wash after plate 4 times, add 100 μ l substrate nitrite ions, 37 ℃, lucifuge colour developing 10min.Reading result under 450nm wavelength.
7, table 2. liang strain monoclonal antibody subgroup identification result
Two, the cross reaction of monoclonal antibody Mab05-F10 and Mab05-D10 test
1, antigen coated: by 78 kind 10
8the pathogenic bacteria of cfu/ml bacterial concentration join in ELISA Plate, and each pathogenic bacteria add 3 holes, every hole 100 μ l, 4 ℃, coated spending the night.
2, sealing: wash after plate 3 times, every hole adds 3%BSA200 μ l, hatches 2h for 37 ℃.
3, wash plate 3 times.Every hole adds the monoclonal antibody 100 μ l that diluted, and hatches 1h for 37 degrees Celsius.
4, wash plate 3 times.Add the mountain sheep anti mouse two having diluted to resist in all micropores, every hole 100 μ l, hatch 1h for 37 degrees Celsius.
5, wash plate 4 times.Add substrate nitrite ion, 37 ℃, lucifuge colour developing 15min.Reading result under 450nm wavelength.
Table 3. liang strain monoclonal antibody cross reaction testing result
Embodiment 3. detects composition, preparation and the application thereof of the enzyme linked immunological kit of Salmonella choleraesuls
One, enzyme linked immunological kit is made up of following substances:
(1) ELISA Plate of pre-coated antibody: with 0.02M acetate buffer solution (pH2.0) solution dilution, the coated 96 hole ELISA Plate of anti-Salmonella choleraesuls monoclonal antibody Mab05-F10, every hole 100 μ l.4 ℃ of overnight incubation, according to conventional ELISA method sealing washing.
(2) Salmonella choleraesuls positive control standard items and negative control standard items.
(3) the monoclonal antibody Mab05-D10 of the anti-Salmonella choleraesuls of horseradish peroxidase-labeled.
(4) enzyme labelled antibody dilution: 0.01M PBS, pH7.6.
(5) 10 × concentrated washing lotion: the 0.1M phosphate buffer that contains 0.5% Tween-20 and 0.2% Sodium azide, pH7.4, will concentrate 10 times of dilutions of washing lotion when use.
(6) nitrite ion A liquid, nitrite ion B liquid.Before using, A liquid is mixed with B liquid equal-volume.
(7) stop buffer: 2M sulfuric acid solution.
Two, the preparation of each component in enzyme linked immunological kit
(1) using Salmonella choleraesuls monoclonal antibody Mab05-F10 as catching antibody coated elisa plate
Salmonella choleraesuls monoclonal antibody Mab05-F10 is diluted to 5 μ g/ml with coated damping fluid, every hole adds 100 μ l, 4 ℃ are spent the night, the coating buffer that inclines next day, washs 3 times by the washing lotion of dilute, pats dry, then in every hole, add 220 μ l confining liquids, 37 ℃ of incubation 2h, liquid in the hole of inclining, preserves with aluminium foil bag sealing after being dried.
Coated damping fluid: 0.02M acetate buffer solution, with 5M HCl adjusting pH to 2.0.
Confining liquid: the 0.01M PBS that contains 0.3% bovine serum albumin(BSA) and 10% sucrose.
(2) preparation of the monoclonal antibody Mab05-D10 of horseradish peroxidase-labeled
Salmonella choleraesuls monoclonal antibody Mab05-D10 and horseradish peroxidase (HRP) are carried out to coupling, and the method for employing is the sodium periodate method of improvement, and method is as follows:
A, 5mg horseradish peroxidase (HRP) are dissolved in 0.5ml0.2M acetate buffer solution (pH5.6).
B, add the 0.06M NaIO of existing preparation
4solution 0.5ml, 4 ℃ of oxidation 20min.
C, add the 0.4M ethylene glycol solution 0.5ml containing 22%NaCl, room temperature leaves standstill 30min.
The absolute ethyl alcohol precipitation enzyme of d, use 6ml precooling, the centrifugal 10min of 1500rpm.
E, remove supernatant, precipitation be dissolved in to the 0.01M PBS(pH7.4 of 2.5ml) in.
F, add 10mg monoclonal antibody Mab05-D10, and use immediately 0.5M carbonic acid buffer (pH9.6) to regulate pH to 9.0.4 ℃ of hold over night.
G, add 10mg/ml sodium borohydride 50 μ l, 4 ℃, leave standstill 2h.
H, use 0.01M PBS(pH7.4) 4 ℃ of dialysed overnight.
I, purification storage.
Three, the application of kit
(1) detection method
1, sample pre-treatments
Get sample 25g(ml to be checked) add 225ml peptone water (BPW) homogeneous under homogenizer to mix, cultivate 16h for 36 ℃ ± 1 ℃.Cultured sample is heated to 10min in 100 ℃ of water-baths.It is stand-by that taking-up is cooled to room temperature.
2, detect with kit
Under the micropore of taking-up requirement and all reagent normal temperature, place 30min.Get 200 μ l sample to be checked and be added in micropore, 37 ℃, hatch 30min.Remove liquid in hole, add 200 μ l washing lotions in each micropore, rock the several seconds gently, fast upset by liquid in micropore to the greatest extent, to a folded clean thieving paper clap several under, repeat operation and wash altogether plate 3 times.Add 100 μ l monoclonal antibody linked with peroxidase Mab05-D10 working fluids, 37 ℃, hatch 60min.Remove in hole liquid and wash plate 4 times.Colour developing A liquid and colour developing B liquid mixed in equal amounts are made into substrate nitrite ion.Each micropore adds the substrate nitrite ion of 100 μ l, room temperature lucifuge colour developing 15-20min.Add stop buffer 100 μ l, under 450nm, measure absorbance by microplate reader.
Result is judged: negative control≤0.1, positive control >=0.3, and experimental result is effective, otherwise that result is judged to be is invalid; Detect OD value >=0.2 o'clock, hole, be judged to be the positive; Detect hole OD value between 0.1-0.2 time, be judged to be the weak positive; Detect OD value≤0.1, hole and be judged to be feminine gender.
If without microplate reader, can with the naked eye judge: there is macroscopic yellow in positive control hole, negative control hole is without color, and experimental result is effective, otherwise it is invalid to be judged to be experimental result; Positive result in the time that there is obvious macroscopic yellow in detection hole; While having faint yellow, be judged to be weak positive findings; Negative result during without naked eyes visible yellow color.
(2) detection of enzyme linked immunological kit effect
1, kit repeatability and stability test
Precision test in plate: get 6 micropores in same ELISA Plate, use the milk being polluted by Salmonella choleraesuls to test, experiment repeats 4 times.
Precision test between plate: get 4 ELISA Plate of same batch, use the milk being polluted by Salmonella choleraesuls to test, experiment repeats 3 times.
The computing method of the coefficient of variation: the coefficient of variation (the CV)=standard deviation of measurement result and the number percent of its mean value.
Reperformance test result in table 4. plate
Reperformance test result between table 5. plate
2, kit cross reaction test
Whether remove to detect other 78 kinds of food-borne pathogens with kit, checking kit detects the specificity of Salmonella choleraesuls, observe and have cross reaction and false positive to occur with other pathogenic bacteria.
The test of table 6. kit specificity
Note: "+" represents that testing result is positive; "-" represents that testing result is negative.
3, kit storage life experiment
Kit preservation condition is 2-8 ℃, and after 12 months, the testing result of kit is consistent with the kit result of new lot.Consider that in transportation and use procedure, having improper preservation condition occurs, kit is placed 8 days under the condition of 37 ℃ of preservations, carry out accelerated aging test, result shows that the indices of kit meets the requirements completely.Therefore kit can at least can be preserved more than 12 months at 2-8 ℃.
The preservation of biomaterial
The hybridoma cell strain Mab05-F10 that produces the Salmonella choleraesuls monoclonal antibody of the above-mentioned evaluation of process is preserved in Chinese common micro-organisms culture presevation administrative center (CGMCC on June 3rd, 2013, China, No. 3, Yard 1, BeiChen xi Road, Chaoyang District, Beijing City, Institute of Microorganism, Academia Sinica, postcode: 100101), preserving number is Chinese common micro-organisms culture presevation administrative center (CGMCC, China, Beijing) No.7712.
The hybridoma cell strain Mab05-D10 that produces the Salmonella choleraesuls monoclonal antibody of the above-mentioned evaluation of process is preserved in Chinese common micro-organisms culture presevation administrative center (CGMCC on June 3rd, 2013, China, No. 3, Yard 1, BeiChen xi Road, Chaoyang District, Beijing City, Institute of Microorganism, Academia Sinica, postcode: 100101), preserving number is Chinese common micro-organisms culture presevation administrative center (CGMCC, China, Beijing) No.7710.
All documents of mentioning in the present invention are all quoted as a reference in this application, are just quoted separately as a reference as each piece of document.In addition should be understood that those skilled in the art can make various changes or modifications the present invention after having read above-mentioned instruction content of the present invention, these equivalent form of values fall within the application's appended claims limited range equally.
Claims (6)
1. for detection of an enzyme linked immunological kit for Salmonella choleraesuls, it is characterized in that, described kit contains:
(a) solid phase carrier, on described solid phase carrier, be coated with as the anti-Salmonella choleraesuls monoclonal antibody Mab05-F10 that catches antibody, described anti-Salmonella choleraesuls monoclonal antibody Mab05-F10 is Mab05-F10 by mouse hybridoma cell, and CGMCC No.7712 produces;
(b) container a, in described container a, be equipped with as the anti-Salmonella choleraesuls monoclonal antibody Mab05-D10 that detects antibody, described anti-Salmonella choleraesuls monoclonal antibody Mab05-D10 is Mab05-D10 by mouse hybridoma cell, and CGMCC No.7710 produces.
2. kit as claimed in claim 1, is characterized in that, described solid phase carrier is enzyme reaction plate.
3. kit as claimed in claim 1, is characterized in that, described detection antibody is with detectable label.
4. kit as claimed in claim 3, is characterized in that, described detectable label is horseradish peroxidase.
5. kit as claimed in claim 1, is characterized in that, described kit also contains positive control and negative control.
6. kit as claimed in claim 5, is characterized in that, the Salmonella choleraesuls bacterium liquid that described positive control is deactivation, the buffered peptone water that described negative control is sterilizing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410065159.1A CN103823062B (en) | 2014-02-25 | 2014-02-25 | Salmonella choleraesuls enzyme-linked immunologic detecting kit |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410065159.1A CN103823062B (en) | 2014-02-25 | 2014-02-25 | Salmonella choleraesuls enzyme-linked immunologic detecting kit |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103823062A true CN103823062A (en) | 2014-05-28 |
| CN103823062B CN103823062B (en) | 2015-09-30 |
Family
ID=50758223
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410065159.1A Expired - Fee Related CN103823062B (en) | 2014-02-25 | 2014-02-25 | Salmonella choleraesuls enzyme-linked immunologic detecting kit |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103823062B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104792991A (en) * | 2015-04-17 | 2015-07-22 | 江南大学 | Specific double antibody sandwich method for detecting salmonella in food based on monoclonal antibody |
| CN105823876A (en) * | 2016-03-18 | 2016-08-03 | 南昌大学 | Salmonella detection method |
| CN106596952A (en) * | 2015-10-15 | 2017-04-26 | 江苏维赛科技生物发展有限公司 | Salmonella cholerae enzyme-linked immunosorbent assay kit |
-
2014
- 2014-02-25 CN CN201410065159.1A patent/CN103823062B/en not_active Expired - Fee Related
Non-Patent Citations (5)
| Title |
|---|
| KRITSANA JANYAPOON等: "Rapid detection of Salmonella enterica serova choleraesuis in blood cultures by a dot blot enzyme-linked immunosorbent assay.", 《CLIN DIAGN LAB IMMUNOL》, vol. 7, no. 6, 30 November 2000 (2000-11-30) * |
| 唐秋艳等主编: "《免疫诊断试剂实用技术》", 31 August 2009, article "酶联免疫诊断技术" * |
| 张平平 等: "6种沙门菌单克隆抗体的制备和效能评价", 《生物技术通讯》, vol. 23, no. 6, 30 November 2012 (2012-11-30) * |
| 文其乙等: "ELISA直接检测鲜奶中的沙门氏菌", 《中国人兽共患病杂志》, no. 06, 20 December 1995 (1995-12-20) * |
| 殷月兰等: "单抗竞争ELISA检测猪沙门氏菌感染方法的建立与应用", 《中国预防兽医学报》, no. 01, 1 January 2003 (2003-01-01) * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104792991A (en) * | 2015-04-17 | 2015-07-22 | 江南大学 | Specific double antibody sandwich method for detecting salmonella in food based on monoclonal antibody |
| CN104792991B (en) * | 2015-04-17 | 2016-08-17 | 江南大学 | The specific diabodies sandwich assay that a kind of detection Salmonella in Food based on monoclonal antibody belongs to |
| CN106596952A (en) * | 2015-10-15 | 2017-04-26 | 江苏维赛科技生物发展有限公司 | Salmonella cholerae enzyme-linked immunosorbent assay kit |
| CN105823876A (en) * | 2016-03-18 | 2016-08-03 | 南昌大学 | Salmonella detection method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103823062B (en) | 2015-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sunwoo et al. | Detection of Escherichia coli O157: H7 using chicken immunoglobulin Y | |
| CN103558388B (en) | Double-antibody sandwich method for detecting salmonella typhimurium in food based on monoclonal antibodies | |
| CN104360065B (en) | Vibrio parahemolyticus enzyme-linked immunologic detecting kit | |
| CN103792361B (en) | Enzyme-linked immunosorbent assay kit of enterohemorrhagic E.col O157:H7 | |
| CN104316690B (en) | Vibrio parahemolyticus immune colloid gold Rapid detection test strip | |
| CN104792991A (en) | Specific double antibody sandwich method for detecting salmonella in food based on monoclonal antibody | |
| CN101362800A (en) | Test strip for rapid detection of brucella | |
| CN103823062B (en) | Salmonella choleraesuls enzyme-linked immunologic detecting kit | |
| CN103940995B (en) | Listeria monocytogenes enzyme-linked immunologic detecting kit | |
| CN104360066B (en) | Detect method and the monoclonal antibody thereof of vibrio parahemolyticus | |
| CN103777017B (en) | Detect method and the monoclonal antibody thereof of enterohemorrhagic Escherichia coli O 157: H7 | |
| CN105223362B (en) | Campylobacter jejuni enzyme-linked immunologic detecting kit | |
| CN103941011B (en) | Detect method and the monoclonal antibody thereof of listeria monocytogenes | |
| CN103848916B (en) | Preparation method, coded sequence and the application thereof of a kind of anti-CP4 EPSPS monoclonal antibody | |
| CN103823063B (en) | Detect method and the monoclonal antibody thereof of Salmonella choleraesuls | |
| CN103869074B (en) | Enzyme-linked immunoassay kit for staphylococcus aureus | |
| CN103913572B (en) | Method for detecting staphylococcus aureus and monoclonal antibodies of staphylococcus aureus | |
| CN103820549B (en) | Salmonella choleraesuis immune PCR detection kit | |
| CN105223363B (en) | The method of detection campylobacter jejuni and monoclonal antibody thereof | |
| CN105132282B (en) | Campylobacter jejuni immuno-PCR detection kit | |
| CN103823060B (en) | Enterohemorrhagic Escherichia coli O 157: H7 immuno-PCR detection kit | |
| CN103866033B (en) | Staphylococcus aureus immune PCR (polymerase chain reaction) detection kit | |
| CN103937898B (en) | Listeria monocytogenes immuno-PCR detection kit | |
| CN104357565B (en) | Vibrio parahemolyticus immuno-PCR detection kit | |
| CN106596952A (en) | Salmonella cholerae enzyme-linked immunosorbent assay kit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150930 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |